Rachna Shroff, MD, FASCO(@rachnatshroff) 's Twitter Profileg
Rachna Shroff, MD, FASCO

@rachnatshroff

GI Oncologist, focus pancreatic, biliary cancers, personalized tx’s. Love to dance, travel, and spend time with my family. ASCO FCOI: https://t.co/oXHqwAT6p6

ID:889727167

linkhttps://cancercenter.arizona.edu/person/rachna-t-shroff-md-ms calendar_today18-10-2012 21:00:36

3,5K Tweets

4,3K Followers

302 Following

Jun Gong(@jgong15) 's Twitter Profile Photo

So cool, colleague pointed this out to me today. Unexpected! But deeply honored to be on the cover OncLive.com with esteemed onc colleagues Anthony El-Khoueiry Rachna Shroff, MD, FASCO Anwaar Saeed Anne Covey MD FSIR Dr. Michael Morse

onclive.com/publications/o…

Cancer at Cedars-Sinai

So cool, colleague pointed this out to me today. Unexpected! But deeply honored to be on the cover @OncLive with esteemed #GI onc colleagues @DrElkhoueiry @rachnatshroff @AnwaarSaeed3 @covey_md Dr. Michael Morse onclive.com/publications/o… @CSCancerCenter
account_circle
OncLive.com(@OncLive) 's Twitter Profile Photo

In this video series, a panel of medical experts discuss key highlights from ASCO GI 2024 surrounding the hepatocellular carcinoma treatment landscape. Rachna Shroff, MD, FASCO Jun Gong Anne Covey MD FSIR Anwaar Saeed Anthony El-Khoueiry onclive.com/view/himalaya-…

account_circle
OncLive.com(@OncLive) 's Twitter Profile Photo

Many patients with HCC historically have faced a poor prognosis and a lack of effective treatment options beyond surgery, but that is beginning to change with the development of new therapeutic approaches. Rachna Shroff, MD, FASCO University of Arizona Cancer Center onclive.com/view/asco-gi-u…

Many patients with HCC historically have faced a poor prognosis and a lack of effective treatment options beyond surgery, but that is beginning to change with the development of new therapeutic approaches. @rachnatshroff @UAZCancer #hcc #oncology onclive.com/view/asco-gi-u…
account_circle
Gevorg Tamamyan(@GevTamamyan) 's Twitter Profile Photo

It is an extreme honor and pleasure to co-chair OncoParty 2024: Summer is Coming (by OncoDaily) Hosting Committee with a great friend and incredible physician-scientist Yelena Y. Janjigian MD! May 31, 8:30pm, Chicago! More details soon!
24

It is an extreme honor and pleasure to co-chair OncoParty 2024: Summer is Coming (by @oncodaily) Hosting Committee with a great friend and incredible physician-scientist @YJanjigianMD! May 31, 8:30pm, Chicago! More details soon! #OncoParty #OncoParty24 #OncoDaily #ASCO
account_circle
University of Arizona Cancer Center(@UAZCancer) 's Twitter Profile Photo

For Women's History Month, the UArizona Cancer Center honors our 78 women members from different specialties throughout the university who make a difference in cancer translational research, prevention and treatment. Learn more about them! cancercenter.arizona.edu/news/2024/03/w… .

For Women's History Month, the UArizona Cancer Center honors our 78 women members from different specialties throughout the university who make a difference in cancer translational research, prevention and treatment. Learn more about them! cancercenter.arizona.edu/news/2024/03/w… #cancer.
account_circle
Gevorg Tamamyan(@GevTamamyan) 's Twitter Profile Photo

💃 🕺 🏋‍The most incredible and the BIGGEST PARTY in Chicago happening during the ASCO Annual Meeting. Mark your calendars for the 'OncoParty 2024: Summer is Coming' by OncoDaily :) May 31st, we are starting at 8:30pm in :)
24

💃 🕺 🏋‍The most incredible and the BIGGEST PARTY in Chicago happening during the ASCO Annual Meeting. Mark your calendars for the 'OncoParty 2024: Summer is Coming' by OncoDaily :) May 31st, we are starting at 8:30pm in #Chicago :) #OncoParty #OncoParty24 #OncoDaily #ASCO
account_circle
Mark Yarchoan(@MarkYarchoan) 's Twitter Profile Photo

Ipi/nivo in 1L is positive! (CheckMate-9DW study). Excited to see the full data soon...
news.bms.com/news/corporate…

account_circle
Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo

Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] Kabir Mody et al. Mark Yarchoan JCO Precision Oncology ascopubs.org/doi/full/10.12…

Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO ascopubs.org/doi/full/10.12… #hpbcsm #PrecisionMedicine
account_circle
Erman Akkus(@Erman_Akkus) 's Twitter Profile Photo

🔎Intrahepatic cholangiocarcinoma (IHCC)

✅Neoadjuvant gemcitabin, cisplatin and nab-paclitaxel (NEO-GAP)
AnnalsSurgOncology

➡️A single arm, phase II trial
➡️30 patients, resectable but high-risk (tumor size > 5 cm, multiple tumors, presence of radiographic major vascular invasion,…

🔎Intrahepatic cholangiocarcinoma (IHCC) ✅Neoadjuvant gemcitabin, cisplatin and nab-paclitaxel (NEO-GAP) @AnnSurgOncol ➡️A single arm, phase II trial ➡️30 patients, resectable but high-risk (tumor size > 5 cm, multiple tumors, presence of radiographic major vascular invasion,…
account_circle